Health Condition 1: null- Periorbital Hyperpigmentation (Dark Circles)
Conditions
Interventions
Intervention1: Autologous Human Platelet Lysate (HPL): Subjects will receive one dose of 5 ml of HPL with simultaneous micro-needling on day 2
Control Intervention1: Standard Therapy: Topical Applicat
Sponsors
KASIAK RESEARCH PRIVATE LIMITED
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects (male and female), aged 18 to 55 years (both inclusive) with Periorbital Hyperpigmentation. 2. Subject willing to refrain from any other treatment of Periorbital Hyperpigmentation during entire study duration. 3. Subjects who are willing to give informed consent and adhere to the study protocol.
Exclusion criteria
Exclusion criteria: 1. Subjects aged less than 18 and more than 55 years 2. Subjects with history of connective tissue disease. 3. Subjects with metabolic or hematopoietic disorders 4. Subjects unwilling to or unable to comply with the study protocol. 5. Subjects taking concomitant therapy that might interfere with the study results in the investigatorâ??s opinion or participating in another trial in the past 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Physicianâ??s assessment scores â?¢ Patientâ??s assessment scores Timepoint: End of Study - 3Months | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Photographic assessmentsTimepoint: End of Study - 3 Months | — |
Countries
India
Contacts
Public ContactDr Kaushal Shah
Shree Krishna Polyclinic
Outcome results
None listed